| |
| |
|
| Insider
Information: |
Canaan Partners X Llc |
| Relationship: |
10% Owner |
| City: |
Westport |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
25,254,545 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$67,503,548 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
25,254,545 |
|
|
| Total
Value |
$67,503,548 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Protagonist Therapeutics, Inc |
PTGX |
10% Owner |
2018-05-17 |
2,116,552 |
2016-08-16 |
0 |
Premium* |
|
|
Iterum Therapeutics Plc |
ITRM |
Director, 10% Owner |
2018-05-30 |
1,733,170 |
2018-05-30 |
0 |
Premium* |
|
|
Nextcure, Inc. |
NXTC |
10% Owner |
2019-05-13 |
2,254,442 |
2019-05-13 |
0 |
Premium* |
|
|
Ideaya Biosciences, Inc. |
IDYA |
10% Owner |
2019-05-28 |
2,660,713 |
2019-05-28 |
0 |
Premium* |
|
|
Astra Space, Inc. |
ASTR |
10% Owner |
2021-12-31 |
16,489,668 |
2021-12-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ASTR |
Astra Space, Inc. |
10% Owner |
– – • |
2021-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,200,000) |
16,489,668 |
0 |
- |
|
| IDYA |
Ideaya Biosciences, Inc. |
10% Owner |
– – • |
2019-05-28 |
4 |
B |
$10.00 |
$4,000,000 |
D/D |
400,000 |
2,660,713 |
2.45 |
- |
|
| IDYA |
Ideaya Biosciences, Inc. |
10% Owner |
– – • |
2019-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,260,713 |
2,260,713 |
0 |
- |
|
| NXTC |
Nextcure, Inc. |
10% Owner |
– – • |
2019-05-13 |
4 |
B |
$15.00 |
$750,000 |
D/D |
50,000 |
2,254,442 |
2.45 |
- |
|
| NXTC |
Nextcure, Inc. |
10% Owner |
– – • |
2019-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,204,442 |
2,204,442 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • • |
2018-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,226,514 |
1,226,514 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • • |
2018-05-30 |
4 |
B |
$13.00 |
$6,586,528 |
D/D |
506,656 |
1,733,170 |
3.92 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2018-05-17 |
4 |
S |
$6.09 |
$237,358 |
D/D |
(38,968) |
2,116,552 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2018-05-16 |
4 |
S |
$6.46 |
$190,071 |
D/D |
(29,441) |
2,155,520 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2018-05-15 |
4 |
S |
$6.48 |
$374,080 |
D/D |
(57,715) |
2,184,961 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2018-05-14 |
4 |
S |
$6.37 |
$494,224 |
D/D |
(77,591) |
2,242,676 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2018-03-23 |
4 |
S |
$20.71 |
$1,241,325 |
D/D |
(59,950) |
2,320,267 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2018-03-22 |
4 |
S |
$20.62 |
$98,133 |
D/D |
(4,759) |
2,380,217 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2018-03-21 |
4 |
S |
$20.61 |
$364,727 |
D/D |
(17,699) |
2,384,976 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2018-03-20 |
4 |
S |
$20.61 |
$351,538 |
D/D |
(17,060) |
2,402,675 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2018-03-19 |
4 |
S |
$20.57 |
$276,446 |
D/D |
(13,439) |
2,419,735 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2018-03-16 |
4 |
S |
$20.51 |
$142,063 |
D/D |
(6,926) |
2,433,174 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2018-03-15 |
4 |
S |
$20.64 |
$242,521 |
D/D |
(11,751) |
2,440,100 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2018-03-14 |
4 |
S |
$20.77 |
$4,154 |
D/D |
(200) |
2,451,851 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2018-03-13 |
4 |
S |
$20.84 |
$25,094 |
D/D |
(1,204) |
2,452,051 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Director |
– • • |
2016-08-16 |
4 |
B |
$12.00 |
$6,999,996 |
D/D |
583,333 |
2,453,255 |
3.92 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Director |
– • • |
2016-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,869,922 |
1,869,922 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
